David García

28.6k total citations · 7 hit papers
189 papers, 11.3k citations indexed

About

David García is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, David García has authored 189 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Cardiology and Cardiovascular Medicine, 106 papers in Internal Medicine and 38 papers in Hematology. Recurrent topics in David García's work include Venous Thromboembolism Diagnosis and Management (106 papers), Atrial Fibrillation Management and Outcomes (93 papers) and Antiplatelet Therapy and Cardiovascular Diseases (25 papers). David García is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (106 papers), Atrial Fibrillation Management and Outcomes (93 papers) and Antiplatelet Therapy and Cardiovascular Diseases (25 papers). David García collaborates with scholars based in United States, Canada and Italy. David García's co-authors include Mark Crowther, Jeffrey I. Weitz, Doruk Erkan, Michael K. Gould, Elaine M. Hylek, Sherry M. Wren, Charles Marc Samama, Juan I. Arcelus, Paul J. Karanicolas and John A. Heit and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

David García

182 papers receiving 10.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention of VTE in Nonorthopedic Surgical Patients

2012 1.5k citations David García et al. CHEST Journal profile →
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

2017 1.1k citations Marc Carrier, David García et al. profile →
Parenteral Anticoagulants

2012 721 citations David García, Trevor Baglin et al. CHEST Journal profile →
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

2015 646 citations David García, Thomas L. Ortel et al. profile →
Diagnosis and Management of the Antiphospholipid Syndrome

2018 491 citations David García et al. profile →
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants

2014 323 citations Adam Cuker, Mark Crowther et al. Journal of the American College of Cardiology profile →
Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis

2018 213 citations Ang Li, David García et al. profile →

Peers

Countries citing papers authored by David García

Since Specialization

Citations

This map shows the geographic impact of David García's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David García with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David García more than expected).

Fields of papers citing papers by David García

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David García. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David García. The network helps show where David García may publish in the future.

Co-authorship network of co-authors of David García

This figure shows the co-authorship network connecting the top 25 collaborators of David García. A scholar is included among the top collaborators of David García based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David García. David García is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Foundations of systems-based hematology: thematic analysis of expert interviews to guide curriculums and promote growth 2025 ·Blood Advances ·(unknown), (unknown), Adam Cuker, David García, Ming Y. Lim, Camila Masias, Jori E. May, Colleen Morton, Jordan K. Schaefer, (unknown), Marc Zumberg, Ariela L. Marshall	0
2	Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial 2025 ·The Journal of Infectious Diseases ·(unknown), Georgina Platt, Charles A. Peloquin, (unknown), Julia Coit, Gustavo E. Velásquez, Henry Pertinez, Diana Vargas, (unknown), Róger Calderón, Judith Jiménez, Karen Tintaya, David García, (unknown), Leonid Lecca, Carole D. Mitnick, Geraint Davies	0
3	Delayed Effects of Different Velocity Loss-Based Resistance Training on Autonomic Regulation, Sleep Quality and Muscle Soreness 2024 ·Journal of Human Kinetics ·Juan Pablo Medellín, (unknown), David García, Luis Manuel Martínez-Aranda	1
4	Inferior Vena Cava Obstruction Complicating Remote Venovenous Extracorporeal Membrane Oxygenation Bridge to Lung Transplantation 2022 ·CHEST Journal ·Taylor D. Coston, Sandeep Vaidya, Jenelle Badulak, David García, Sioḃán Keel, Michael S. Mulligan, Kathleen J. Ramos, Siddhartha G. Kapnadak	2
5	Vitamin K antagonist reversal strategies: Systematic review and network meta‐analysis from the AABB 2022 ·Transfusion ·Monica B. Pagano, Farid Foroutan, Ruchika Goel, Elizabeth S. Allen, (unknown), David García, (unknown), Kimberly Klein, Jay S. Raval, Claudia S. Cohn	4
6	Endometriosis Increases the Risk of Placenta Previa in Both IVF Pregnancies and the General Obstetric Population 2022 ·Reproductive Sciences ·(unknown), Jorge Burgos, Rosario Mendoza, (unknown), (unknown), David García, Iker Malaina, Roberto Matorras	4
7	ISTH definition of pulmonary embolism‐related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort 2021 ·Journal of Thrombosis and Haemostasis ·Tobias Tritschler, Steven Salvatore, Susan R. Kahn, David García, Aurélien Delluc, Noémie Kraaijpoel, Nicole Langlois, Philippe Girard, Grégoire Le Gal	1
8	Cost‐effectiveness analysis of low‐dose direct oral anticoagulant (DOAC) for the prevention of cancer‐associated thrombosis in the United States 2020 ·Cancer ·Ang Li, Josh J. Carlson, Nicole M. Kuderer, Jordan K. Schaefer, Shan Li, David García, Alok A. Khorana, Marc Carrier, Gary H. Lyman	24
9	Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta‐analysis 2020 ·Journal of Thrombosis and Haemostasis ·Thomas L. Ortel, Sreelatha Meleth, Diane Catellier, Mark Crowther, Doruk Erkan, Paul R. Fortin, David García, (unknown), Andrzej S. Kosinski, Steven R. Levine, M. Phillips, Nedra Whitehead	24
10	Implementation of an experiential learning strategy to reduce the risk of ventilator-associated pneumonia in critically ill adult patients 2019 ·Journal of the Intensive Care Society ·Hernán Michelángelo, Federico Angriman, Rodolfo Pizarro, (unknown), (unknown), (unknown), David García, (unknown), (unknown), Cristina Ferrari	7
11	Practical considerations for the use of direct oral anticoagulants in oncology patients 2019 ·Journal of Oncology Pharmacy Practice ·(unknown), (unknown), (unknown), (unknown), Eve M. Segal, David García	2
12	Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes 2017 ·Journal of Thrombosis and Thrombolysis ·Bethany Samuelson Bannow, Roland B. Walter, Terry Gernsheimer, David García	32
13	Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation 2014 ·Journal of the American College of Cardiology ·Greg Flaker, Renato D. Lópes, Elaine M. Hylek, Daniel Wojdyla, Laine Thomas, Sana M. Al‐Khatib, Renee M. Sullivan, Stefan H. Hohnloser, David García, Michael Hanna, John Amerena, Veli-Pekka Harjola, Paul Dorian, Álvaro Avezum, Mátyás Keltai, Lars Wallentin, Christopher B. Granger	81
14	Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review 2013 ·Blood ·David García, Elie A. Akl, (unknown), Clive Kearon	99
15	Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants 2012 ·Journal of Thrombosis and Haemostasis ·David García, (unknown), Eduardo Ramacciotti, Jeffrey I. Weitz	85
16	Parenteral Anticoagulants breakdown → 2012 ·CHEST Journal ·David García, Trevor Baglin, Jeffrey I. Weitz, M Samama	721
17	Clinical Significance Statement 2011 ·The American Journal of Medicine ·Kim A. Eagle, David S. Cannom, David García	7
18	Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy 2009 ·Journal of Thrombosis and Haemostasis ·Daniel M. Witt, Thomas Delate, (unknown), Mary Beth Dowd, Nathan P. Clark, Mark Crowther, David García, Walter Ageno, Francesco Dentali, Elaine M. Hylek, William G. Rector	62
19	Epidemiology and Risk Factors of Venous Thromboembolism 2006 ·Seminars in Thrombosis and Hemostasis ·Walter Ageno, Alessandro Squizzato, David García, Davide Imberti	97
20	Warfarin Maintenance Dosing Patterns in Clinical Practice 2005 ·CHEST Journal ·David García, Susan Regan, Mark Crowther, Robert A Hughes, Elaine M. Hylek	176

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact